CHARACTERIZATION OF SOMAN-BINDING ANTIBODIES RAISED AGAINST SOMAN ANALOGS

被引:9
作者
GLIKSON, M
ARADYELLIN, R
GHOZI, M
RAVEH, L
GREEN, BS
ESHHAR, Z
机构
[1] HEBREW UNIV JERUSALEM,SCH PHARM,DEPT PHARMACEUT CHEM,JERUSALEM,ISRAEL
[2] ISRAEL INST BIOL RES,IL-70450 NESS ZIONA,ISRAEL
[3] WEIZMANN INST SCI,DEPT CHEM IMMUNOL,IL-76100 REHOVOT,ISRAEL
[4] WEIZMANN INST SCI,DEPT ORGAN CHEM,IL-76100 REHOVOT,ISRAEL
关键词
D O I
10.1016/0161-5890(92)90128-K
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The production of antibodies against the highly toxic organophosphorus compound soman (GD) has been undertaken. Monoclonal antibodies were raised against two structural analogs of soman which served as haptens for immunization. In these soman analogs the chemically active P-F bond of the soman molecule was substituted by a P-OH group (which is ionized to P-O-under physiological conditions) or a P-H bond, creating compounds which we have named GDOH and GDH, respectively. These soman analogs were linked to carrier proteins through a short linker extending from the pinacolyl group. Monoclonal antibodies were selected according to their ability to bind to the immunizing hapten, and their specificities were determined by competitive inhibition assays. Out of total of 103 anti-GDOH antibodies 22 bound soman, whereas no binding was achieved with 62 anti-GDH antibodies. The two groups of monoclonal antibodies differed also in their structural specificity as demonstrated by different reactivities against a variety of soman analogs and substituted derivatives. These studies indicate that in order to achieve further improvement in anti-soman reactivity with protective potential, other groups (which resemble the OH group) have to be substituted for the F atom in the soman molecule.
引用
收藏
页码:903 / 910
页数:8
相关论文
共 22 条
[1]  
BRIMFIELD AA, 1985, MOL PHARMACOL, V28, P32
[2]  
BUENAFE AC, 1989, J IMMUNOL, V143, P539
[3]   COMBINING SITE SPECIFICITY OF MONOCLONAL-ANTIBODIES TO THE ORGANOPHOSHPATE HAPTEN SOMAN [J].
BUENAFE, AC ;
RITTENBERG, MB .
MOLECULAR IMMUNOLOGY, 1987, 24 (05) :401-407
[4]  
COOK CE, 1985, A BIOSCI REV, P67
[5]   PROGRESS IN MEDICAL DEFENSE AGAINST NERVE AGENTS [J].
DUNN, MA ;
SIDELL, FR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (05) :649-652
[6]   DETECTION OF THE ORGANOPHOSPHORUS NERVE AGENT SOMAN BY AN ELISA USING MONOCLONAL-ANTIBODIES [J].
ERHARD, MH ;
KUHLMANN, R ;
SZINICZ, L ;
LOSCH, U .
ARCHIVES OF TOXICOLOGY, 1990, 64 (07) :580-585
[7]  
Eshhar Z, 1985, HYBRIDOMA TECHNOLOGY, P1
[8]  
GREEN BS, 1991, BIOTECHNOLOGY : BRIDGING RESEARCH AND APPLICATIONS, P249
[9]   CLINICAL PROBLEMS IN ORGANO-PHOSPHATE INSECTICIDE POISONING - THE USE OF A COMPUTERIZED INFORMATION-SYSTEM [J].
HIRSHBERG, A ;
LERMAN, Y .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1984, 4 (02) :S209-S214
[10]   QUANTIFICATION OF THE ORGANO-PHOSPHORUS NERVE AGENT SOMAN BY COMPETITIVE-INHIBITION ENZYME-IMMUNOASSAY USING MONOCLONAL-ANTIBODY [J].
HUNTER, KW ;
LENZ, DE ;
BRIMFIELD, AA ;
NAYLOR, JA .
FEBS LETTERS, 1982, 149 (01) :147-151